Perindopril oral - GenePreDiT

Drug Profile

Perindopril oral - GenePreDiT

Latest Information Update: 24 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gene PreDiT
  • Developer Blueclinical; Gene PreDiT
  • Class Antihypertensives; Indoles; Small molecules
  • Mechanism of Action ACE inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Obesity

Most Recent Events

  • 24 May 2017 Chemical structure information added
  • 28 Apr 2017 Gene PreDiT and Blueclinical terminate a phase II trial in Obesity (In adults, In the elderly, Diagnosis) in Portugal (EudraCT2015-004275-70)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top